Bexson Biomedical announced today that it appointed Sheldon Moberg as its new senior vice president of drug delivery.
Santa Barbara, Calif.-based Bexson said in a news release that Moberg will lead the development of its drug delivery technologies, starting with a wearable infusion device for its BB106 therapy developed in partnership with Stevanato Group.
Get the full story at our sister site, Drug Delivery Business News.